- Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion The Wall Street Journal
- Roche to acquire liver drug developer 89bio for up to $3.5 billion Reuters
- RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline Yahoo Finance
- Roche to buy metabolic biotech 89bio for up to $3.5B Axios
- Roche enters into a definitive merger agreement to acquire GlobeNewswire
Source link
